Swiss medtech startup CHD (Connected Health Development) has received around €160,000 (CHF 150,000) in funding from Venture Kick. The company will use the funding to develop its digital technology for remotely monitoring mothers and unborn babies, especially during high-risk pregnancies. Its solutions aim to help healthcare professionals monitor patients without requiring them to visit hospitals as often.
More than 140 million babies are born worldwide each year. Around 15% of pregnancies are considered high-risk and require regular medical checks. Frequent hospital visits can be difficult for expectant mothers and put extra pressure on healthcare teams. Staff shortages and limited hospital capacity also make it harder to provide regular care.
CHD is developing connected healthcare technology that combines medical sensors, digital platforms and data analysis. These tools allow healthcare professionals to monitor patients remotely and make better-informed medical decisions. The company aims to improve access to maternal care, identify possible complications earlier and reduce unnecessary hospital visits.
One of its key products is MONI2, a smart textile belt that can be washed and worn by pregnant women. The belt collects information about the mother and unborn baby, including electrocardiogram (ECG) signals, uterine contractions, fetal movements and the baby’s position.
Pregnant women can check basic health information through a smartphone app. At the same time, healthcare professionals can access detailed medical data and predictive indicators through a secure online portal. This information helps them monitor pregnancies and identify potential health concerns.
CHD plans to launch both consumer and medical versions of MONI2 using the same hardware. The company aims to sell more than 30,000 kits and subscriptions within four years.
Commenting on the investment, Laurent Vandebrouck, CEO of CHD, said, “Venture Kick’s support forms part of the company’s initial seed fundraising effort. He added that other private investors and a foundation have already committed or are considering funding, with CHD aiming to complete the round by October.”
The funding will help CHD develop and test its MONI2 technology and make sure it works reliably. The company will use the support to prepare its remote monitoring solutions for mothers and unborn babies for commercial launch.
